FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890861636> ?p ?o ?g. }

• W2890861636 endingPage "819" @default.
• W2890861636 startingPage "812" @default.
• W2890861636 abstract "Breast cancer is reported a very complex disease along with heterogeneous morphological characteristics and unrelated clinical behavior, and is a leading cancer among female. Nevertheless, chemo-resistance is frequently observed. Adriamycin (ADM) is a always employed drug to treat clinical breast cancer. However, strong resistance to ADM limited its clinical efficacy. Deregulation of HDAC6 activity is linked to various diseases including cancer resulting in accumulating interest for developing HDAC6 inhibitors. In the present study, for the first time, we found that 4-Hydroxybenzoic acid (4-HBA), as histone deacetylase 6 (HDAC6) inhibitor, could successfully reverse ADM resistance in human breast cancer cells. 4-HBA significantly promoted the anticancer effect of ADM on apoptosis induction, as evidenced by the increased expressions of Caspase-3 and PARP cleavage, which was associated with the promotion p53 and homeodomain interacting protein kinase-2 (HIPK2) expressions in ADM-resistant breast cancer cells. Furthermore, the suppressive effect of ADM on drug-resistant breast cancer cells was accelerated by 4-HBA through increasing the number of cells distributed in G2/M phase of cell cycle arrest. Inhibiting HIPK2/p53 pathway could abolish 4-HBA/ADM co-treatment-induced apoptosis and G2/M cell cycle arrest. Importantly, HDAC6 expressions were also significantly down-regulated in ADM-resistance breast cancer cells co-treated with ADM and 4-HBA. Additionally, 4-HBA clearly potentiated the anticancer role of ADM in the MCF-7 breast cancer animal model with low toxicity. Therefore, 4-HBA could be applied as an effective HDAC6 inhibitor to reverse human breast cancer resistance. Herein, the 4-HBA and ADM combination might represent as a useful therapeutic strategy to prevent human breast cancer." @default.
• W2890861636 created "2018-09-27" @default.
• W2890861636 creator A5012173556 @default.
• W2890861636 creator A5058582007 @default.
• W2890861636 creator A5069255958 @default.
• W2890861636 creator A5088888341 @default.
• W2890861636 creator A5090448113 @default.
• W2890861636 date "2018-10-01" @default.
• W2890861636 modified "2023-10-17" @default.
• W2890861636 title "4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway" @default.
• W2890861636 cites W1534569692 @default.
• W2890861636 cites W1963718127 @default.
• W2890861636 cites W1969342645 @default.
• W2890861636 cites W1969674563 @default.
• W2890861636 cites W1969701476 @default.
• W2890861636 cites W1976738338 @default.
• W2890861636 cites W1996778928 @default.
• W2890861636 cites W2029148944 @default.
• W2890861636 cites W2033148489 @default.
• W2890861636 cites W2035721941 @default.
• W2890861636 cites W2046316599 @default.
• W2890861636 cites W2051759456 @default.
• W2890861636 cites W2060902443 @default.
• W2890861636 cites W2063500255 @default.
• W2890861636 cites W2069887628 @default.
• W2890861636 cites W2081094284 @default.
• W2890861636 cites W2088415033 @default.
• W2890861636 cites W2091885586 @default.
• W2890861636 cites W2098089867 @default.
• W2890861636 cites W2099803844 @default.
• W2890861636 cites W2099875690 @default.
• W2890861636 cites W2109125373 @default.
• W2890861636 cites W2112238025 @default.
• W2890861636 cites W2114579003 @default.
• W2890861636 cites W2115593774 @default.
• W2890861636 cites W2117629868 @default.
• W2890861636 cites W2132066963 @default.
• W2890861636 cites W2134691115 @default.
• W2890861636 cites W2180779342 @default.
• W2890861636 cites W2190954851 @default.
• W2890861636 cites W2411700647 @default.
• W2890861636 doi "https://doi.org/10.1016/j.bbrc.2018.08.043" @default.
• W2890861636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30217455" @default.
• W2890861636 hasPublicationYear "2018" @default.
• W2890861636 type Work @default.
• W2890861636 sameAs 2890861636 @default.
• W2890861636 citedByCount "36" @default.
• W2890861636 countsByYear W28908616362019 @default.
• W2890861636 countsByYear W28908616362020 @default.
• W2890861636 countsByYear W28908616362021 @default.
• W2890861636 countsByYear W28908616362022 @default.
• W2890861636 countsByYear W28908616362023 @default.
• W2890861636 crossrefType "journal-article" @default.
• W2890861636 hasAuthorship W2890861636A5012173556 @default.
• W2890861636 hasAuthorship W2890861636A5058582007 @default.
• W2890861636 hasAuthorship W2890861636A5069255958 @default.
• W2890861636 hasAuthorship W2890861636A5088888341 @default.
• W2890861636 hasAuthorship W2890861636A5090448113 @default.
• W2890861636 hasConcept C104317684 @default.
• W2890861636 hasConcept C121608353 @default.
• W2890861636 hasConcept C126322002 @default.
• W2890861636 hasConcept C185592680 @default.
• W2890861636 hasConcept C190283241 @default.
• W2890861636 hasConcept C23681527 @default.
• W2890861636 hasConcept C2778305200 @default.
• W2890861636 hasConcept C29537977 @default.
• W2890861636 hasConcept C502942594 @default.
• W2890861636 hasConcept C530470458 @default.
• W2890861636 hasConcept C55493867 @default.
• W2890861636 hasConcept C64927066 @default.
• W2890861636 hasConcept C71924100 @default.
• W2890861636 hasConcept C96232424 @default.
• W2890861636 hasConcept C98274493 @default.
• W2890861636 hasConceptScore W2890861636C104317684 @default.
• W2890861636 hasConceptScore W2890861636C121608353 @default.
• W2890861636 hasConceptScore W2890861636C126322002 @default.
• W2890861636 hasConceptScore W2890861636C185592680 @default.
• W2890861636 hasConceptScore W2890861636C190283241 @default.
• W2890861636 hasConceptScore W2890861636C23681527 @default.
• W2890861636 hasConceptScore W2890861636C2778305200 @default.
• W2890861636 hasConceptScore W2890861636C29537977 @default.
• W2890861636 hasConceptScore W2890861636C502942594 @default.
• W2890861636 hasConceptScore W2890861636C530470458 @default.
• W2890861636 hasConceptScore W2890861636C55493867 @default.
• W2890861636 hasConceptScore W2890861636C64927066 @default.
• W2890861636 hasConceptScore W2890861636C71924100 @default.
• W2890861636 hasConceptScore W2890861636C96232424 @default.
• W2890861636 hasConceptScore W2890861636C98274493 @default.
• W2890861636 hasIssue "4" @default.
• W2890861636 hasLocation W28908616361 @default.
• W2890861636 hasLocation W28908616362 @default.
• W2890861636 hasOpenAccess W2890861636 @default.
• W2890861636 hasPrimaryLocation W28908616361 @default.
• W2890861636 hasRelatedWork W2027079605 @default.
• W2890861636 hasRelatedWork W2341629494 @default.
• W2890861636 hasRelatedWork W2348413169 @default.
• W2890861636 hasRelatedWork W2386605958 @default.
• W2890861636 hasRelatedWork W2387384092 @default.

• next